SYROS PHARMAC.NEW DL-,001SYROS PHARMAC.NEW DL-,001SYROS PHARMAC.NEW DL-,001

SYROS PHARMAC.NEW DL-,001

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪123.07 M‬EUR
−4.64EUR
‪−149.11 M‬EUR
‪9.00 M‬EUR
‪19.89 M‬
Beta (1Y)
1.17

About Syros Pharmaceuticals, Inc.

Headquarters
Cambridge
Website
Employees (FY)
68
Founded
2011
FIGI
BBG00DLD6HM1
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by Richard A. Young, Nathanael S. Gray, and James E. Bradner on November 9, 2011 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SYROS PHARMAC.NEW DL-,001 stocks are traded under the ticker 0S90.
We've gathered analysts' opinions on SYROS PHARMAC.NEW DL-,001 future price: according to them, 0S90 price has a max estimate of 34.44 EUR and a min estimate of 11.17 EUR. Watch 0S90 chart and read a more detailed SYROS PHARMAC.NEW DL-,001 stock forecast: see what analysts think of SYROS PHARMAC.NEW DL-,001 and suggest that you do with its stocks.
0S90 reached its all-time high on Jan 10, 2024 with the price of 7.44 EUR, and its all-time low was 0.72 EUR and was reached on Sep 19, 2022. View more price dynamics on 0S90 chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track SYROS PHARMAC.NEW DL-,001 financials in yearly and quarterly reports right on TradingView.
SYROS PHARMAC.NEW DL-,001 is going to release the next earnings report on Aug 6, 2024. Keep track of upcoming events with our Earnings Calendar.
0S90 earnings for the last quarter are −0.09 EUR per share, whereas the estimation was −0.79 EUR resulting in a 88.20% surprise. The estimated earnings for the next quarter are −0.71 EUR per share. See more details about SYROS PHARMAC.NEW DL-,001 earnings.
SYROS PHARMAC.NEW DL-,001 revenue for the last quarter amounts to 0 EUR despite the estimated figure of ‪667.28 K‬ EUR. In the next quarter revenue is expected to reach ‪423.62 K‬ EUR.
0S90 net income for the last quarter is ‪−3.44 M‬ EUR, while the quarter before that showed ‪−58.33 M‬ EUR of net income which accounts for 94.11% change. Track more SYROS PHARMAC.NEW DL-,001 financial stats to get the full picture.
No, 0S90 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 29, 2024, the company has 68.00 employees. See our rating of the largest employees — is SYROS PHARMAC.NEW DL-,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SYROS PHARMAC.NEW DL-,001 EBITDA is ‪−113.37 M‬ EUR, and current EBITDA margin is ‪−1.25 K‬%. See more stats in SYROS PHARMAC.NEW DL-,001 financial statements.
Like other stocks, 0S90 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SYROS PHARMAC.NEW DL-,001 stock right from TradingView charts — choose your broker and connect to your account.